Pharmaceutical Technology Europe, May 1, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, May 1, 2010
Special Feature
Understanding powder behaviour
By Tim Freeman
The needs of the pharmaceutical industry for powder testing technologies are changing, primarily for two reasons.
When and why should the pharmaceutical industry use NIR chemical imaging?
By Janie Dubois
The author assesses the power and limitations of NIR chemical imaging and its future.
Bioanalysis: hurdles and hopes
By Patrick Bennett
Bioanalysis has migrated from a very general vocation to one that requires more specialization, particularly in GLP applications.
Innovations in dissolution testing
By Tony Copley
Advances in dissolution testing technology have been one of the biggest breakthroughs in solid dosage form testing over the last decade.
Manufacturing
Do emerging markets provide the answer to the pharmaceutical industry?
By Luigi G. Martini , Sandy Macrae
The emerging markets represent an attractive investment opportunity for the pharmaceutical industry because of the countries' growing economies and unmet medical needs.
REACH: has the cloud of confusion cleared?
By Malcolm Pollard
The pharmaceutical industry must understand its responsibilities to improve the safety of chemicals as defined by the REACH initiative.
Regulation
Change management: common failures and a checklist for improvement
By Henrik Johanning , John V. Lee , Christian Hemmingsen
Though the pharma industry has improved its change management processes, there are still opportunities for improvement.
Formulation
Obtaining simultaneous multiple dissolution profiles of solid oral dosage formulations
By Ana Rita Pires , D. López Malo , J. Martínez Calatayud
Testing the dissolution rates of a pharmaceutical formulation (also known as in vitro availability) aids drug quality control and is a compulsory requirement of the British, European and US pharmacopoeias.
Ask the Expert
The possibilities and challenges of spray drying
By Henrik Schwartzbach
Why spray drying processes offer a range of particle engineering possibilities.
Outsourcing Review
The Lilly Way
By Jim Miller
Lilly faces up to the new realities of the bio/pharmaceutical industry by embracing outsourcing.
Spotlight
Change is in the air for the European Clinical Trials Directive
By Faiz Kermani
Though many advantages are associated with the European Clinical Trials Directive, complexities have emerged since its introduction in 2004. Since 2007, efforts have been made to raise the issues and address the negative impact of the Directive.
News
News
A round up of news from across the globe.
Editor's Comment
What do you think?
By Fedra Pavlou
Over the last few months, we have been publishing a series of special features, which have sought to provide you with an overall view of current challenges, innovations and trends in niche pockets of the pharmaceutical industry.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
25%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
11%
Regulatory compliance
36%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here